Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients-Reference-Cited by-同舟云学术

Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients

Published:2022-01-06 Issue:1 Volume:139 Page:134-137
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Maillard Alexis¹^ORCID,Redjoul Rabah²,Klemencie Marion³,Labussière Wallet Hélène⁴,Le Bourgeois Amandine⁵,D'Aveni Maud⁶,Huynh Anne⁷^ORCID,Berceanu Ana⁸,Marchand Tony⁹,Chantepie Sylvain¹⁰^ORCID,Botella Garcia Carmen¹¹,Loschi Michael¹²,Joris Magalie¹³,Castilla-Llorente Cristina¹⁴,Thiebaut-Bertrand Anne¹⁵,François Sylvie³,Leclerc Mathieu²,Chevallier Patrice¹⁶,Nguyen Stephanie¹

Affiliation:

1. Department of Clinical Hematology, Hôpitaux Universitaires Pitié Salpêtrière, Paris, France;

2. Department of Clinical Hematology, Assistance Publique des Hôpitaux de Paris (APHP), Hôpital Henri Mondor, Créteil, France;

3. Department of Clinical Hematology, Angers University Hospital, Angers, France;

4. Department of Clinical Hematology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France;

5. Department of Clinical Hematology, Nantes University Hospital, Nantes, France;

6. Department of Hematology, Nancy Hospital, Nancy, France;

7. Department of Hematology, Institut Universitaire du Cancer Toulouse–Oncopole, Service de greffe de cellules souches hematopoïétiques, Toulouse, France;

8. Department of Clinical Hematology, Besançon University Hospital, Besançon, France;

9. Department of Clinical Hematology, Centre Hospitalier Universitaire (CHU) de Rennes, Rennes, France;

10. Institut d'Hématologie de Basse Normandie, Centre Hospitalier Universitaire de Caen, Caen;

11. Department of Hematology and Cell Therapy, CHU de Bordeaux, Bordeaux, France;

12. Department of Hematology, CHU de Nice, Université Cote d'Azur, Nice, France;

13. Department of Hematology, CHU Amiens, Amiens, France;

14. Institut de Cancérologie Gustave Roussy, Villejuif, France;

15. Department of Clinical Hematology, CHU de Grenoble, Grenoble, France; and

16. Department of Clinical Hematology, Nantes University Hospital, Nantes, France

Abstract

Three reports address the protection of the vulnerable population of patients with hematologic malignancies in the face of the ongoing COVID pandemic. The reports suggest that some patients who fail to mount a B-cell response to vaccine may nevertheless have protective T cell responses. As a group, these reports suggest that patients should continue to be immunized with additional doses to attempt to improve immune response but that they need to maintain the precautions recommended for the unvaccinated.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

https://ashpublications.org/blood/article-pdf/139/1/134/1857720/bloodbld2021014232.pdf

Reference19 articles.

1. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey;Ljungman;Leukemia.,2021

2. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med.,2021

3. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med.,2020

4. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients;Kamar;N Engl J Med.,2021

5. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients;Boyarsky;JAMA.,2021

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating uncharted waters: assessing the impact of the COVID-19 pandemic on hematopoietic stem cell transplantation: challenges and innovations;Annals of Medicine & Surgery;2024-08-07

2. Cellular and humoral immunogenicity against SARS-CoV-2 vaccination or infection is associated with the memory phenotype of T- and B-lymphocytes in adult allogeneic hematopoietic cell transplant recipients;International Journal of Hematology;2024-06-06

3. Immunogenicity of mRNA-1273 and BNT162b2 in Immunocompromised Patients: Systematic Review and Meta-analysis Using GRADE;Infectious Diseases and Therapy;2024-05-27

4. Immunologic responses to the third and fourth doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in cell therapy recipients: a systematic review and meta-analysis;Virology Journal;2024-05-03

5. Spike-Specific Memory B Cell Response in Hematopoietic Cell Transplantation Recipients following Multiple mRNA-1273 Vaccinations: A Longitudinal Observational Study;Vaccines;2024-03-29